| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | CCG-100602 |
|---|
| Description | Inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC3 prostate cancer cells with an IC50 value of 9.8 μM |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Rho signaling signal transduction cancers inhibitors SRF serum response factors transcription CCG-1423 megakaryoblastic leukemia 1 MKL1 prostate analogs PC-3 CCG100602 CCG 100602 CCG1423 CCG 1423 cells DNA binding RHOA/C-mediated MKL-1 |
|---|
| Gene, Accession, CAS # | CAS: 1207113-88-9 |
|---|
| Catalog # | 10787-50 |
|---|
| Price | |
|---|
| Order / More Info | CCG-100602 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|